CSF2 and neoplasm: Additionally, several other studies have exemplified the efficacy of Gemogenovatucel-T—a TAV that consists of autologous tumor cells transfected with a plasmid containing the GM-CSF gene, an immune-stimulatory cytokine, and a bifunctional short hairpin construct that inhibits furin—in treating ovarian cancer patients [57].